Form 8-K ARTELO BIOSCIENCES, INC. For: May 11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Artelo Biosciences terminates at-the-market offering agreement
May 15, 2026 4:03 PM EDTArtelo Biosciences Inc. (NASDAQ: ARTL) terminated its at-the-market offering agreement with R.F. Lafferty & Co., Inc., the company announced. The termination notice was provided on May 11, 2026, with the agreement ending on May 18, 2026.
The sales agreement, originally dated July 18, 2025, allowed Artelo to sell... More
